Document is current
Any future updates will be listed below
-
Authors
Zhao, Xin
Varisco, Rachel
Borghouts, Judith
Eikey, Elizabeth V.
Safani, David
Mukamel, Dana B.
Schueller, Stephen M.
Sorkin, Dara H.
-
Funding
Funding for this research was provided by:
Orange County Health Care Agency (MA-042-21011324, MA-042-21011324, MA-042-21011324, MA-042-21011324, MA-042-21011324, MA-042-21011324, MA-042-21011324, MA-042-21011324)
Institute for Clinical and Translational Sciences (UL1TR001414, UL1TR001414, UL1TR001414)
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 24 April 2024
First Online: 9 May 2024
Declarations
:
: Our institutional review board deemed that this work was exempt from human participant research approval (University of California, Irvine Institutional Review Board# #20195406). Key informant interviews are considered non-human subject research because results are intended to describe the specific context under which the data is collected, and will not be used to generalize beyond this context. Verbal informed consent was obtained from all participants.
: Not applicable.
: SMS has received consulting payments from Otsuka Pharmaceuticals and Boehringer Ingelheim, and is a member of the Headspace Scientific Board, for which he receives compensation. XZ has received consulting payments from FirstThen Inc for work unrelated to this manuscript. The authors have no further interests to declare.
